PASITHEA THERAPEUTICS CORP. Investment Income, Net
PASITHEA THERAPEUTICS CORP. (KTTA) reported Investment Income, Net of $176.74 thousand for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeNet · last filed 2023-11-13
- PASITHEA THERAPEUTICS CORP. investment income, net for the quarter ending 2023-09-30 was $176.74K.
- PASITHEA THERAPEUTICS CORP. investment income, net for the quarter ending 2022-09-30 was -$335.32K.
| Period end | Investment Income, Net 3 month | Investment Income, Net 9 month |
|---|---|---|
| 2023-09-30 | $176.74K 10-Q · filed 2023-11-13 | $354.10K 10-Q · filed 2023-11-13 |
| 2022-09-30 | -$335.32K 10-Q · filed 2023-11-13 | $871.68K 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |